中国慢性肾脏病患者高血压管理指南(2023年版)

Guidelines for hypertension management in patients with chronic kidney disease in China(2023)

中国慢性肾脏病(chronic kidney disease,CKD)高血压人群具有病因复杂、发病率高、知晓率和控制率低等特点,如何规范合理诊治CKD患者高血压并改善其预后,日前尤为需要。国内外已颁布了多个高血压诊治及管理的临床指南或专家共识,其中有涉及CKD患者高血压诊疗的部分内容,但仍不能满足CKD高血压诊疗需求。中华医学会肾脏病学分会基于中国CKD患者高血压发病情况,组织了专家组撰写本指南,从CKD患者高血压的诊断标准,流行病学,危险因素,不良结局,降压治疗的目的、时机和控制目标,特殊人群的血压控制目标,非药物治疗与药物治疗等方面进行系统介绍。该指南旨在进一步加强CKD患者高血压的管理,规范其诊疗标准,制定合理治疗方案,有效控制高血压,减少并发症发生,从而延缓肾脏病进展、改善中国CKD患者高血压远期预后。

The population of chronic kidney disease(CKD)with hypertension in China is characterized by complex etiology,high incidence rate,low awareness and control rate.How to diagnose and treat hypertension in CKD patients properly and improve their prognosis is particularly urgent.Several clinical guidelines or expert consensus on the diagnosis,treatment and management of hypertension have been issued.Some of them involve the diagnosis and treatment of hypertension in CKD patients,but they still can not meet the demand for diagnosis and treatment of hypertension in CKD patients.Based on the situation of hypertension in CKD patients in China,the Chinese Society of Nephrology organized an expert group to formulate this guideline.This guideline systematically introduces the diagnostic criteria,epidemiology,risk factors,poor prognosis of hypertension,the purpose,timing and control goals of antihypertensive therapy in CKD patients,as well as blood pressure control goals for special populations,non drug treatment and drug treatment of hypertension.This guideline aims to further strengthen the management of hypertension in CKD patients,standardize the diagnosis and treatment standards,formulate reasonable treatment plans,effectively control hypertension,reduce complications,so as to delay the progress of kidney diseases and improve the long-term prognosis of hypertension in Chinese CKD patients.